title: Is tacrolimus effective for treating antisynthetase-associated interstitial lung disease?
authors.affiliation: Division of Rheumatology, Mayo Clinic, Rochester, MN 55905, USA. bongartz.tim@mayo.edu
authors.forename: Tim
authors.initials: T
authors.lastname: Bongartz
authors.forename: Jay H
authors.initials: JH
authors.lastname: Ryu
authors.forename: Eric L
authors.initials: EL
authors.lastname: Matteson
mesh_terms: D000604:Amino Acyl-tRNA Synthetases / Q000276:immunology*; D001323:Autoantibodies / Q000276:immunology*; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D017563:Lung Diseases, Interstitial / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D011653:Pulmonary Diffusing Capacity / Q000502:physiology; D012189:Retrospective Studies; D016559:Tacrolimus / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D001323:Autoantibodies; D007166:Immunosuppressive Agents; D000604:Amino Acyl-tRNA Synthetases; D016559:Tacrolimus